Central Serous Chorioretinopathy

Primary Investigator: Andre Witkin, MD

Title: Eplerenone for the Treatment of Central Serous Chorioretinopathy
Sponsor: New England Eye Center of Tufts Medical Center

Brief Summary
This is a pilot study to test the effect of oral eplerenone in patients with both acute and chronic central serious chorioretinopathy (CSCR).

Inclusion Criteria
Sub-retinal fluid under fovea seen on OCT
Diagnosis of Acute or Chronic CSCR

Study Length and Visits: 5 study visits over a 1-month period

Age Ra: ge: 18+ years


Payment: None

Contact: Carly Satsuma, 617-636-5489